Skip to content
Drug recall · FDA · Published April 8, 2019

American Health Packaging recalls GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health

American Health Packaging recalls GlipiZIDE Extended-release Tablets due to dissolution failure at time zero, potentially affecting drug release. Check NDC 68084-295-21 and lot 181288.

🇺🇸 FDA recall #D-1276-2019DrugAmerican Health Packaging ›
Take action

Contact the company & request your remedy

Recalling firmAmerican Health Packaging2550 John Glenn Ave Ste A, N/A · Columbus, OH 43217-1188
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

American Health Packaging recalls GlipiZIDE Extended-release Tablets (2.5 mg, 30 tablets) because they failed dissolution tests at time zero. This could mean the medication doesn't release properly when taken, which might affect treatment effectiveness. Read more at govinfonow.com/recall/38946-american-health-glipizide-extended-release-tablets-recall-dissolution-failure-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38946-american-health-glipizide-extended-release-tablets-recall-dissolution-failure-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1276-2019

Cite this page

“American Health GlipiZIDE Extended-release Tablets Recall: Dissolution Failure Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38946-american-health-glipizide-extended-release-tablets-recall-dissolution-failure-risk. Based on FDA recall #D-1276-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1276-2019%22&limit=1).

Why it’s dangerous

The tablets failed dissolution tests at time zero, meaning they didn't release the medication properly when first exposed to water. This could lead to inconsistent drug levels in the body, potentially reducing effectiveness.

Who’s affected

People with a prescription for GlipiZIDE Extended-release Tablets who received this specific lot (NDC 68084-295-21, lot 181288) are affected. Those taking blood pressure medication are most at risk if the tablets don't dissolve correctly.

How to tell if you have this one

Check for the NDC code 68084-295-21 and lot number 181288 on the packaging. The product was distributed by American Health Packaging and sold with an expiration date of May 31, 2020.

  • Brand
    American Health Packaging
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 68084-295-21 and lot number 181288 on the packaging.

✎ GovInfoNow

Questions people ask

Is this product safe to take?

The recall is due to dissolution failure at time zero, which may affect medication release. Consult your doctor or pharmacist for advice on whether to continue using the product.

How can I check if I have the recalled product?

Check the NDC code 68084-295-21 and lot number 181288 on the packaging. The product was distributed by American Health Packaging with an expiration date of May 31, 2020.

What should I do if I have the recalled product?

The recall record does not specify a remedy, so contact your doctor or pharmacist for guidance on next steps.

Take action

Contact American Health Packaging

We’ve drafted a message you can send American Health Packaging to request your refund or repair — edit it as you like.

Subject: Recall D-1276-2019 — American Health Packaging American Health Packaging

Hello,

I own a American Health Packaging that is covered by recall D-1276-2019 from American Health Packaging.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1276-2019 (April 8, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1276-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA